Vitamin e and memantine in Alzheimer's disease: Clinical trial methods and baseline data

Alzheimer's and Dementia

Volumn 10, Issue 1, 2014, Pages 36-44

  Dysken, Maurice W ^a   Guarino, Peter D ^b   Vertrees, Julia E ^c   Asthana, Sanjay ^d   Sano, Mary ^e   Llorente, Maria ^f   Pallaki, Muralidhar ^g   Love, Susan ^a   Schellenberg, Gerard D ^h   McCarten, J Riley ^a   Malphurs, Julie ⁱ   Prieto, Susana ⁱ   Chen, Peijun ^g   Loreck, David J ^j   Carney, Sara ^k   Trapp, George ^l   Bakshi, Rajbir S ^l   Mintzer, Jacobo E ^m   Heidebrink, Judith L ⁿ   Vidal Cardona, Ana ^o   Arroyo, Lillian M ^o   Cruz, Angel R ^k   Kowall, Neil W ^p   Chopra, Mohit P ^p   Craft, Suzanne ^q   Thielke, Stephen ^q   Turvey, Carolyn L ^r   Woodman, Catherine ^r   Monnell, Kimberly A ^s   Gordon, Kimberly ^s   Tomaska, Julie ^a   Vatassery, Govind ^a   more..

^a Minneapolis VA Healthcare System   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c University of New Mexico   (United States)

^d WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^e VISN 3 Mental Illness Research and Clinical Center   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ VETERANS AFFAIRS MEDICAL CENTER   (United States)

^j UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^k VETERANS AFFAIRS MEDICAL CENTER   (United States)

^l VA North Texas Health Care System   (United States)

^m MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

ⁿ VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^o VA Caribbean Healthcare System Puerto Rico   (Puerto Rico)

^p VA BOSTON HEALTHCARE SYSTEM   (United States)

^q UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^r UNIVERSITY OF IOWA   (United States)

^s WG (Bill) Hefner Medical Center   (United States)

more..

Author keywords

Alpha tocopherol; Alzheimer's disease; Cholinesterase inhibitors; Memantine; Randomized trials; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; DONEPEZIL; GALANTAMINE; MEMANTINE; PLACEBO; RIVASTIGMINE;

ADULT; AGED; ALZHEIMER DISEASE; ALZHEIMER DISEASE ASSESSMENT SCALE; ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; VERY ELDERLY;

ALPHA-TOCOPHEROL; ALZHEIMER'S DISEASE; CHOLINESTERASE INHIBITORS; MEMANTINE; RANDOMIZED TRIALS; VITAMIN E;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIOXIDANTS; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEMANTINE; PSYCHIATRIC STATUS RATING SCALES; VETERANS; VITAMIN E;

EID: 84891165230     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2013.01.014     Document Type: Article

References (41)

1. P. Davies Studies on the neurochemistry of central cholinergic systems in Alzheimer's disease R. Katzman, R.D. Terry, K.L. Bick, Alzheimer's disease: senile dementia and related disorders 1978 Raven Press New York 453 459
2. W.R. Markesbery The roles of oxidative stress in Alzheimer disease Arch Neurol 56 1999 1449 1452
3. R. Cacabelos, M. Takeda, and B. Winblad The glutamatergic system and neurodegeneration in dementia: preventive strategies in Alzheimer's disease Int J Geriatr Psychiatry 14 1999 3 47 (Pubitemid 29046036)
4. S.A. Lipton, and P.A. Rosenberg Excitatory amino acids as a final common pathway for neurologic disorders N Engl J Med 330 1994 613 622
5. M. Sano, C. Ernesto, R.G. Thomas, M.R. Klauber, K. Schafer, and M. Grundman et al. A controlled trial of selegiline, alpha-tocopherol or both as treatment for Alzheimer's disease N Engl J Med 336 1997 1216 1222 (Pubitemid 27183651)
6. W. Danysz, and C. Parsons The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence Int J Geriatr Psychiatry 18 2003 S23 S32
7. G. McKhann, D.D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force in Alzheimer's disease Neurology 34 1984 939 944 (Pubitemid 14076461)
8. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician J Psychiatry Res 12 1975 189 198
9. D. Galasko, D. Bennet, M. Sano, C. Ernesto, R. Thomas, and M. Gundman et al. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease Alzheimer Dis Assoc Disord 11 1997 S33 S39
10. B. Reisberg, R. Doody, A. Stoffler, F. Schmitt, S. Ferris, and H.J. Mobius Memantine in moderate-to-severe Alzheimer's disease N Engl J Med 348 2003 1333 1341 (Pubitemid 36384100)
11. P.N. Tariot, M.R. Farlow, G.T. Grossberg, S.M. Graham, S. McDonald, and I. Gergel Memantine treatment in patients with moderate-to-severe Alzheimer disease already receiving donepezil JAMA 291 2004 317 324 (Pubitemid 38101604)
12. P.S. Aisen, K.A. Schafer, M. Grundman, E. Pfeiffer, M. Sano, K.L. Davis Alzheimer's Disease Cooperative Study Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial JAMA 289 2003 2819 2826 (Pubitemid 37430117)
13. M. Oremus, A. Perrault, L. Demers, and C. Wolfson Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of global scales J Geriatr Psychiatry Neurol 13 2000 197 205 (Pubitemid 32055168)
14. R.C. Mohs, W.G. Rosen, and K.L. Davis The Alzheimer's Disease Assessment Scale: an instrument for assessing treatment efficacy Psychopharmacol Bull 19 1983 448 450 (Pubitemid 13041813)
15. W.G. Rosen, R.C. Mohs, and K.L. Davis A new rating scale for Alzheimer's disease Am J Psychiatry 141 1984 1356 1364
16. Y. Stern, S.M. Albert, M. Sano, M. Richards, L. Miller, and M. Folstein et al. Assessing patient dependence in Alzheimer's disease J Gerontol 49 1994 M216 M222
17. J.L. Cummings, M. Mega, K. Gray, S. Rosenberg-Thompson, D. Carusi, and J. Gornbein The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia Neurology 44 1994 2308 2314 (Pubitemid 24382728)
18. K. Davis, D. Marin, R. Kane, D. Patrick, E. Peskind, and M. Raskind et al. The Caregiver Activity Survey (CAS): development and validation of a new measure for caregivers of persons with Alzheimer's disease Int J Geriatr Psychiatry 11 1997 978 988 (Pubitemid 27480222)
19. E. Lonn, J. Bosch, S. Yusuf, P. Sheridan, T. Pogue, and J.M. Arnold Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial JAMA 293 2005 1338 1347 (Pubitemid 40381486)
20. J.L. Haybittle Significance testing in the comparison of survival curves from clinical trials of cancer treatment Eur J Cancer Clin Oncol 22 1986 1279 1283 (Pubitemid 17183451)
21. Y. Hochberg A sharper Bonferroni procedure for multiple tests of significance Biometrika 75 1988 800 802
22. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383 (Pubitemid 17055592)
23. S.K. Rigler, S. Studenski, D. Wallace, D.M. Reker, and P.W. Duncan Co-morbidity adjustment for functional outcomes in community-dwelling older adults Clin Rehabil 16 2002 420 428 (Pubitemid 34746048)
24. S. Studenski, S.M. Lai, P.W. Duncan, and S.K. Rigler The impact of self-reported cumulative comorbidity on stroke recovery Ageing 33 2004 195 198 (Pubitemid 38313122)
25. J.D. Grill, and J. Karlawish Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials Alzheimers Res Ther 2 2010 34
26. E.R. Miller, R. Pastor-Barriuso, D. Dalal, R.A. Riemersma, L.J. Appel, and E. Guallar Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality Ann Int Med 142 2005 37 46
27. M.W. Dysken, L.N. Kirk, and M. Kuskowski Changes in vitamin E prescribing for Alzheimer patients Am J Geriatr Psychiatry 17 2009 621 624
28. P.S. Aisen, L.S. Schneider, M. Sano, R. Diaz-Arrastia, C.H. van Dyck, and M.F. Weiner High-dose B vitamin supplementation and cognitive decline in Alzheimer disease JAMA 300 2008 1774 1783
29. R.S. Doody, S.I. Gavrilova, M. Sano, R.G. Thomas, P.S. Aisen, and S.O. Bachurin et al. Effect of dimebon on cognition, activities of daily living, behavior, and global function in patients with mild-to-moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled study Lancet 372 2008 207 215 (Pubitemid 351978110)
30. J.F. Quinn, R. Raman, R.G. Thomas, K. Yurko-Mauro, E.B. Nelson, and C. Van Dyck et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer's disease: a randomized trial JAMA 304 2011 1903 1911
31. R.C. Green, L.S. Schneider, D.A. Amato, A.P. Beelen, G. Wilcock, and E.A. Swabb et al. Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized trial JAMA 302 2009 2557 2564
32. S. Gilman, M. Koller, R.S. Black, L. Jenkins, S.G. Griffith, and N.C. Fox et al. Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial Neurology 64 2005 1553 1562 (Pubitemid 40617691)
33. S. Salloway, R. Sperling, S. Gilman, N.C. Fox, K. Blennow, and M. Raskind et al. A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease Neurology 73 2009 2061 2070
34. J. Birks Cholinesterase inhibitors for Alzheimer's disease Cochrane Database Syst Rev 1 2006 CD005593
35. E.R. Peskind, S.G. Potkin, N. Pomara, B.R. Ott, S.M. Graham, and J.T. Olin et al. Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial Am J Geriatr Psychiatry 14 2006 704 715 (Pubitemid 44196270)
36. A.P. Porsteinsson, G.T. Grossberg, J. Mintzer, J.T. Olin Memantine MEM-MD-12 Study Group Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial Curr Alzheimer Res 5 2008 83 89 (Pubitemid 351536358)
37. S. Bakchine, and H. Loft Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study J Alzheimers Dis 13 2008 97 107 (Pubitemid 351365621)
38. S.M. Lippman, E.A. Klein, P.J. Goodman, M.S. Lucia, I.M. Thompson, and L.G. Ford et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) JAMA 301 2009 39 51
39. E.A. Klein, I.M. Thompson Jr., C.M. Tangen, J.J. Crowley, M.S. Lucia, and P.J. Goodman et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) JAMA 306 2011 1549 1556
40. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers N Engl J Med 330 1994 1029 1035
41. J.M. Gaziano, R.J. Glynn, W.G. Christen, T. Kurth, C. Belanger, and J. MacFadyen et al. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial JAMA 301 2009 52 62